您的位置: 首页 > 农业专利 > 详情页

MVA-BN AND AD26.ZEBOV OR AD26.FILO PRIME-BOOST REGIMEN
专利权人:
Janssen Vaccines &; Prevention B.V.;Bavarian Nordic A/S
发明人:
Benoit Christophe Stephan CALLENDRET,Kerstin LUHN-WEGMANN
申请号:
US16500567
公开号:
US20200101153A1
申请日:
2018.04.06
申请国别(地区):
US
年份:
2020
代理人:
摘要:
Compositions and methods are described for generating an improved effective immune response against an immunogen in humans. The enhanced immune response, is obtained by using an MVA vector as a prime, an adenovirus vector as a first boost, and an adenovirus vector as a second boost. The compositions and methods can be used to provide a protective immunity against a disease, such as an infection of one or more subtypes of Ebola and Marburg filoviruses, in humans.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充